Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection.
about
Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicansRodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus.Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.Differences in efficacy and cytokine profiles following echinocandin or liposomal amphotericin B monotherapy or combination therapy for murine pulmonary or systemic Aspergillus flavus infectionsRole of innate immune receptors in paradoxical caspofungin activity in vivo in preclinical aspergillosis.Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidiaPosaconazole: a new broad-spectrum antifungal agent.Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.Use of posaconazole in the treatment of invasive fungal infections.Echinocandins in antifungal pharmacotherapy.Posaconazole: A new agent for the prevention and management of severe, refractory or invasive fungal infections.Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview.Synergistic effect of posaconazole and caspofungin against clinical zygomycetes.
P2860
Q28487653-D40569A0-2B6D-4365-B77E-D1D011351862Q33689767-E1198F1C-995C-43F8-A798-717062DCD2CEQ35076940-0ADF434A-FDB2-4B73-9A6B-CB4B79F4BC43Q35647724-6250A931-0203-404C-A67A-B4FC492DAD43Q35666612-00427978-005B-4729-8739-F87F023336A1Q36171611-2A9FFE7E-9935-4662-852A-5A248CA83626Q36422666-60ADE00D-B402-498E-9616-6EC4C535E63BQ36828159-AAC6F57C-3DCA-413C-9443-7EA431502D38Q37404840-D63C84CE-B0D7-42BC-AB9E-056126382196Q37810083-960728EB-047E-4601-A583-B3E681F49222Q39458862-19776C4E-47B5-4337-AFA4-76ABDAF85A8BQ41848545-1B8E67A2-42BD-40FA-ACC5-A557A7AD4542Q42413286-663CEA3F-8955-450B-825A-79268176B8E7Q42627361-64A6359B-9158-40B6-99D9-2A59E81D6B5A
P2860
Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Interaction between posaconazo ...... ystemic Aspergillus infection.
@ast
Interaction between posaconazo ...... ystemic Aspergillus infection.
@en
Interaction between posaconazo ...... ystemic Aspergillus infection.
@nl
type
label
Interaction between posaconazo ...... ystemic Aspergillus infection.
@ast
Interaction between posaconazo ...... ystemic Aspergillus infection.
@en
Interaction between posaconazo ...... ystemic Aspergillus infection.
@nl
prefLabel
Interaction between posaconazo ...... ystemic Aspergillus infection.
@ast
Interaction between posaconazo ...... ystemic Aspergillus infection.
@en
Interaction between posaconazo ...... ystemic Aspergillus infection.
@nl
P2093
P2860
P356
P1476
Interaction between posaconazo ...... ystemic Aspergillus infection.
@en
P2093
Anthony Cacciapuoti
Cara Mendrick
Christine Norris
David Loebenberg
Judith Halpern
Reena Patel
P2860
P304
P356
10.1128/AAC.00829-05
P407
P577
2006-07-01T00:00:00Z